Press-release for stocks related to vaccine

Prices are updated after-hours

tags : Vaccine

save search

Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
MRNA M | $173.27 -1.75% -1.78% 2.8M

Health Technology

| -1.39% | O: -1.39% H: 0.0% C: 0.0%
PSNL | $3.92 28.95% 22.45% 7.8M

Health Technology

| 1.32% | O: 1.32% H: 0.0% C: 0.0%
trials vaccine mrna agreement cancer

Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates
Published: 2023-02-01 (Crawled : 14:20) - globenewswire.com
BWV A | $1.245 -0.4% -0.4% 82K

| 1.63% | O: -2.44% H: 8.33% C: 4.17%
water partnership monkeypox for vaccine blue

GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
GRNA | $1.135 1.34% 1.32% 220K

Professional, Scientific, and T...

| 6.16% | O: 9.76% H: 0.0% C: -5.87%
covid-19 candidate vaccine mrna trial approval

Global Hepatitis B Virus (HBV) Vaccine Market Report 2023-2027 Featuring GSK, Merck, Sanofi, Dynavax, LG Chem, VBI Vaccines and Meiji Group Among Others
Published: 2023-01-31 (Crawled : 21:00) - prnewswire.com
SNY | News | $46.02 -2.58% -2.65% 3.5M

Health Technology

| -5.88% | O: -0.51% H: 0.0% C: 0.0%
DVAX | $11.69 -1.6% -1.63% 1.5M

Health Technology

| 0.18% | O: -0.7% H: 2.08% C: 0.88%
hepatitis global report vaccine virus group market

Aeolian Biotech Corp. Formed to Create an Improved Pneumococcal Vaccine with Experienced Vaccine Development Leadership Team
Published: 2023-01-30 (Crawled : 00:00) - biospace.com/
PFE | $44.06 -0.63% -0.02% 24M

Health Technology

| 0.38% | O: -0.79% H: 0.0% C: 0.0%
JNJ | News | $164.61 -0.56% -0.01% 6.8M

Health Technology

| -1.6% | O: -0.26% H: 0.0% C: 0.0%
SNY | News | $46.02 -2.58% -2.65% 3.5M

Health Technology

| -5.32% | O: 0.95% H: 0.0% C: 0.0%
DVAX | $11.69 -1.6% -1.63% 1.5M

Health Technology

| -3.23% | O: -1.49% H: 0.0% C: 0.0%
biotech vaccine

CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs
Published: 2023-01-30 (Crawled : 15:00) - biospace.com/
CVAC | $11.055 -5.35% -5.65% 540K

Health Technology

| 2.64% | O: 5.54% H: 0.0% C: 0.0%
covid-19 vaccine mrna positive

Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
Published: 2023-01-30 (Crawled : 13:00) - biospace.com/
MRNA M | $173.27 -1.75% -1.78% 2.8M

Health Technology

| -9.21% | O: -2.73% H: 0.0% C: 0.0%
rna-1345 fda designation candidate for vaccine respiratory virus granted therapy

Europe Human Papillomavirus Vaccine Market Report 2022: Sector to Reach $1.59 Billion by 2028 at a 4.9% CAGR
Published: 2023-01-27 (Crawled : 01:00) - prnewswire.com
GSK | $34.83 -0.85% 0.03% 3.6M

Health Technology

| 0.14% | O: 0.06% H: 0.0% C: 0.0%
SNY | News | $46.02 -2.58% -2.65% 3.5M

Health Technology

| -6.5% | O: -1.25% H: 0.0% C: 0.0%
europe report vaccine market

AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
Published: 2023-01-26 (Crawled : 12:20) - globenewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M

Health Technology

| -3.78% | O: 1.48% H: 0.34% C: -0.85%
ACIU | $2.42 -2.42% -2.48% 86K

Health Technology

| 5.29% | O: 14.1% H: 0.0% C: -7.34%
aci-24 for vaccine trial alzheimer’s positive aci-24.060 anti-amyloid beta

GeoVax Receives Notice of Allowance for Zika Vaccine Patent
Published: 2023-01-25 (Crawled : 20:00) - globenewswire.com
GOVX | $0.9401 2.19% 2.14% 740K

Health Technology

| 31.69% | O: 8.79% H: 0.0% C: 0.0%
patent for vaccine

Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
Published: 2023-01-24 (Crawled : 14:20) - biospace.com/
DYAI | $1.86 1.36% 46K

Health Technology

| 14.11% | O: 5.52% H: 1.74% C: -1.17%
dyai-100 covid-19 candidate for antibody vaccine trial response

mRNA Vaccine Market to Reach $91.14 Billion by 2029
Published: 2023-01-24 (Crawled : 13:20) - prnewswire.com
SNY | News | $46.02 -2.58% -2.65% 3.5M

Health Technology

| -5.98% | O: -0.72% H: 0.0% C: 0.0%
SGMO | $3.515 -4.22% -4.41% 1.1M

Health Technology

| 6.38% | O: -1.16% H: 1.76% C: 1.17%
CVAC | $11.055 -5.35% -5.65% 540K

Health Technology

| 11.45% | O: -3.82% H: 4.07% C: 1.49%
vaccine mrna market

J&J Shuts Down Second HIV Vaccine Trial in as Many Years
Published: 2023-01-19 (Crawled : 14:00) - biospace.com/
JNJ | News | $164.61 -0.56% -0.01% 6.8M

Health Technology